Back to search

Article

Ceramide-induced Endoplasmic Reticulum Stress as a Targetable Vulnerability in Endocrine Therapy-Resistant Breast Cancer

2025-08-22

Abstract excerpt

<h4>ABSTRACT</h4> Despite the success of endocrine therapy (ET) in treating hormone receptor-positive breast cancer, a significant proportion of patients relapse during or after treatment, making ET resistance a major clinical challenge. Previously we have shown that ET-resistant breast cancer cells exhibit reduced ceramide levels and an increased sensitivity to ceramide-induced cell death. Here, we demonstrate t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
25f0fa87-cccd-546b-95b9-31e9e0365782
DOI
10.1101/2025.08.18.670862
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ceramide-induced Endoplasmic Reticulum Stress as a Targetable Vulnerability in Endocrine Therapy-Resistant Breast CancerDOI 10.1101/2025.08.18.670862
Select a neighboring publication to make it the new centre.